Cargando…
Conclusions regarding the efficacy of treatments for neuroleptic malignant syndrome should be tempered given poor quality data, regardless of the analysis conducted
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206394/ https://www.ncbi.nlm.nih.gov/pubmed/17488492 http://dx.doi.org/10.1186/cc5786 |
_version_ | 1782148461502660608 |
---|---|
author | Roberts, Darren M Roberts, Jason A |
author_facet | Roberts, Darren M Roberts, Jason A |
author_sort | Roberts, Darren M |
collection | PubMed |
description | |
format | Text |
id | pubmed-2206394 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-22063942008-01-19 Conclusions regarding the efficacy of treatments for neuroleptic malignant syndrome should be tempered given poor quality data, regardless of the analysis conducted Roberts, Darren M Roberts, Jason A Crit Care Letter BioMed Central 2007 2007-05-02 /pmc/articles/PMC2206394/ /pubmed/17488492 http://dx.doi.org/10.1186/cc5786 Text en Copyright © 2007 BioMed Central Ltd |
spellingShingle | Letter Roberts, Darren M Roberts, Jason A Conclusions regarding the efficacy of treatments for neuroleptic malignant syndrome should be tempered given poor quality data, regardless of the analysis conducted |
title | Conclusions regarding the efficacy of treatments for neuroleptic malignant syndrome should be tempered given poor quality data, regardless of the analysis conducted |
title_full | Conclusions regarding the efficacy of treatments for neuroleptic malignant syndrome should be tempered given poor quality data, regardless of the analysis conducted |
title_fullStr | Conclusions regarding the efficacy of treatments for neuroleptic malignant syndrome should be tempered given poor quality data, regardless of the analysis conducted |
title_full_unstemmed | Conclusions regarding the efficacy of treatments for neuroleptic malignant syndrome should be tempered given poor quality data, regardless of the analysis conducted |
title_short | Conclusions regarding the efficacy of treatments for neuroleptic malignant syndrome should be tempered given poor quality data, regardless of the analysis conducted |
title_sort | conclusions regarding the efficacy of treatments for neuroleptic malignant syndrome should be tempered given poor quality data, regardless of the analysis conducted |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206394/ https://www.ncbi.nlm.nih.gov/pubmed/17488492 http://dx.doi.org/10.1186/cc5786 |
work_keys_str_mv | AT robertsdarrenm conclusionsregardingtheefficacyoftreatmentsforneurolepticmalignantsyndromeshouldbetemperedgivenpoorqualitydataregardlessoftheanalysisconducted AT robertsjasona conclusionsregardingtheefficacyoftreatmentsforneurolepticmalignantsyndromeshouldbetemperedgivenpoorqualitydataregardlessoftheanalysisconducted |